Chrome Extension
WeChat Mini Program
Use on ChatGLM

Therapeutic Implementation in Arterial Thrombosis with Pulmonary Administration of Fucoidan Microparticles Containing Acetylsalicylic Acid.

International Journal of Pharmaceutics(2022)SCI 2区

Fed Univ Rio Grande | Univ Fed Rio de Janeiro | Fed Univ Rio Janeiro | Laboratory of Biochemical Pharmacology

Cited 2|Views19
Abstract
Several antithrombotic drugs are available to treat cardiovascular diseases due to its high mortality and morbidity worldwide. Despite these, severe adverse effects that can lead to treatment withdrawal have been described, highlighting the importance of new therapies. Thus, this work describes the development of fucoidan microparticles containing acetylsalicylic acid (MP/F4M) for pulmonary delivery and in vitro, ex vivo, and in vivo evaluation. Microparticles were prepared via spray-drying and characterized in vitro (mucoadhesive properties, coagulation time, platelet aggregation, adhesion, and hemolysis) followed by ex vivo platelet aggregation, in vivo arterial thrombosis, and hemorrhagic profile. The formulation physicochemical characterization showed suitable characteristics along with delayed drug release, increased breathable particle fraction, and high washability resistance as well as antiplatelet activity and enhanced platelet adhesion in vitro. In in vivo assays, MP/F4M protected against arterial thrombosis, without changes in the hemorrhagic profile. Finally, no lung changes were observed after prolonged pulmonary administration, whereas isolated ASA led to an inflammatory response. In conclusion, pulmonary administration of fucoidan microparticles with an antiplatelet drug may be an alternative therapy to treat cardiovascular diseases, opening the field for different formulations.
More
Translated text
Key words
Microtechnology,Pulmonary administration,Thrombosis,Platelets,Acetylsalicylic acid,Fucoidan
求助PDF
上传PDF
Bibtex
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Upload PDF to Generate Summary
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:本研究创新性地开发了一种含有乙酰水杨酸的岩藻多糖微粒子(MP/F4M),通过肺途径递送,用于治疗动脉血栓,降低了副作用,提高了治疗效果。

方法】:通过喷雾干燥法制备了岩藻多糖微粒子,并在体外对其进行了特性评估,包括黏膜附着性、凝血时间、血小板聚集、吸附和溶血等。

实验】:完成了体外、离体和体内评估实验,使用了MP/F4M微粒子,数据集未在文本中明确提及,实验结果表明微粒子具有延迟释药、增加可呼吸粒子分数、高洗涤抗力以及抗血小板活性和增强的血小板吸附能力,在体内实验中能够预防动脉血栓形成,且不改变出血状况,长期肺递送后未观察到肺部变化,而单独使用乙酰水杨酸会导致炎症反应。